首页> 美国卫生研究院文献>other >VARIATION IN CO-MEDICATION USE ACCORDING TO KIDNEY TRANSPLANT IMMUNOSUPPRESSIVE REGIMENS: APPLICATION OF INTEGRATED REGISTRY AND PHARMACY CLAIMS DATA

【2h】

VARIATION IN CO-MEDICATION USE ACCORDING TO KIDNEY TRANSPLANT IMMUNOSUPPRESSIVE REGIMENS: APPLICATION OF INTEGRATED REGISTRY AND PHARMACY CLAIMS DATA

机译：肾脏移植免疫抑制治疗方案在联合用药中的应用变化：综合注册和药物治疗数据的应用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundModern immunosuppression therapies (ISx) have many side effects, and transplant recipients must take an array of “co-medications” to help mitigate complications. Co-medication use patterns are not well described in large, representative samples due to lack of data.

机译：背景技术现代的免疫抑制疗法（ISx）具有许多副作用，并且移植接受者必须采取一系列“联合用药”以帮助减轻并发症。由于缺乏数据，在大型的代表性样本中没有很好地描述共同用药的使用模式。

著录项

期刊名称 other
作者
Krista L. Lentine; Abhijit S. Naik; Mark Schnitzler; David Axelrod; Jiajing Chen; Daniel C. Brennan; Dorry L. Segev; Bertram L. Kasiske; Henry Randall; Vikas R. Dharnidharka;
展开▼
作者单位

展开▼
年(卷),期 -1(48),1
年度 -1
页码 55–58
总页数 8
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data [J] . Lentine K. L., Naik A. S., Schnitzler M., Transplantation Proceedings . 2016,第1期

机译：根据肾脏移植免疫抑制方案的喜剧使用中的变化：综合注册表和药房索赔数据的应用
2. Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data [J] . Vest L. S., Koraishy F. M., Zhang Z., Clinical transplantation. . 2018,第8期

机译：二甲双胍在肾脏移植后的第一年使用，相关，糖尿病移植受者的相关结果：综合登记和药学声明数据的回顾性分析
3. Understanding medical care of transplant recipients through integrated registry and pharmacy claims data [J] . LentineK.L., AnyaegbuE., GleisnerA., American Journal of Nephrology . 2013,第5期

机译：通过集成的注册表和药房索赔数据了解移植受者的医疗情况
4. Newly developed preconditioning regimen consisting of rituximab, splenectomy and plasmapheresis for non-responders to conventional regimen in ABO-incompatible kidney transplantation [C] . Satoshi Teraoka, Koutaro Kai, Kazuhiro Iwato, Nihon Ishoku Gakkai . 2006

机译：新开发的预处理方案，由rituximab，脾切除术和血浆的非响应者对常规方案组成，在Abo-Indompative肾移植中
5. Applications of Data Analytic Modeling for Efficient Stem-Cell Transplants and Donor Registry Management [D] . Sivasankaran, Adarsh. 2018

机译：数据分析模型在高效干细胞移植和供体登记管理中的应用
6. Metformin Use in the First Year after Kidney Transplant Correlates and Associated Outcomes in Diabetic Transplant Recipients: A Retrospective Analysis of Integrated Registry and Pharmacy Claims Data [O] . LS Vest, FM Koraishy, Z Zhang, -1

机译：肾脏移植后第一年使用二甲双胍与糖尿病移植受者的相关和相关结局相关：对注册管理机构和药房索赔数据的回顾性分析
7. Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data [O] . K.L. Lentine, A.S. Naik, M. Schnitzler, 2016

机译：根据肾移植免疫抑制方案的复合使用的变异：综合登记和药房索赔数据的应用

VARIATION IN CO-MEDICATION USE ACCORDING TO KIDNEY TRANSPLANT IMMUNOSUPPRESSIVE REGIMENS: APPLICATION OF INTEGRATED REGISTRY AND PHARMACY CLAIMS DATA

摘要

著录项

相似文献

相关主题

期刊订阅